All In Biotech

Drugs by condition

Drugs approved for kidney cancer (renal cell carcinoma)

Brand-name prescription drugs and biologics whose FDA label lists kidney cancer (renal cell carcinoma) as an approved use. Matched on the label phrases: "renal cell carcinoma".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

24

Still marketed, NDA or BLA

Drug classes

8

Novel drugs

15

New molecular entities and new biologics

In development

29

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for kidney cancer (renal cell carcinoma).

  • Omcazio (Cabozantinib Laurylsulfate) · Handa Oncol Sep 3, 2026
  • Keytruda Qlex (Pembrolizumab, Berahyaluronidase Alfa-Pmph) · Merck Sharp Dohme NovelAccelerated approvalPriority reviewSep 19, 2025
  • Jobevne (Bevacizumab-Nwgd) · Biocon Biologics INC Apr 9, 2025
  • Opdivo Qvantig (Nivolumab, Hyaluronidase-Nvhy) · Bristol-Myers Squibb Accelerated approvalDec 27, 2024
  • Vegzelma (Bevacizumab-Adcd) · Celltrion Sep 27, 2022

All approved drugs for kidney cancer (renal cell carcinoma), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 24 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Vascular Endothelial Growth Factor Inhibitor (6)

  • Avastin Bevacizumab · Genentech · 2004
  • Jobevne Bevacizumab-Nwgd · Biocon Biologics INC · 2025
  • Vegzelma Bevacizumab-Adcd · Celltrion · 2022
  • Alymsys Bevacizumab-Maly · Amneal Pharms LLC · 2022
  • Zirabev Bevacizumab-Bvzr · Pfizer INC · 2019
  • Mvasi Bevacizumab-Awwb · Amgen INC · 2017

Kinase Inhibitor (5)

  • Lenvima Lenvatinib Mesylate · Eisai INC · 2015
  • Inlyta Axitinib · Pf Prism Cv · 2012
  • Afinitor Everolimus · Novartis · 2009
  • Nexavar Sorafenib Tosylate · Bayer Hlthcare · 2005
  • Afinitor Disperz Everolimus · Novartis Pharm · 2012

Endoglycosidase (2)

  • Keytruda Qlex Pembrolizumab, Berahyaluronidase Alfa-Pmph · Merck Sharp Dohme · 2025
  • Opdivo Qvantig Nivolumab, Hyaluronidase-Nvhy · Bristol-Myers Squibb · 2024

Programmed Death Receptor-1 Blocking Antibody (2)

  • Opdivo Nivolumab · Bristol Myers Squibb · 2014
  • Keytruda Pembrolizumab · Merck Sharp Dohme · 2014

Programmed Death Ligand-1 Blocker (1)

  • Bavencio Avelumab · Emd Serono INC · 2017

CTLA-4-directed Blocking Antibody (1)

  • Yervoy Ipilimumab · Bristol Myers Squibb · 2011

Lymphocyte Growth Factor (1)

Class not listed in FDA's data (6)

  • Fotivda Tivozanib Hydrochloride · Aveo Pharms · 2021
  • Votrient Pazopanib Hydrochloride · Novartis · 2009
  • Torisel Temsirolimus · Pf Prism Cv · 2007
  • Sutent Sunitinib Malate · Cppi Cv · 2006
  • Omcazio Cabozantinib Laurylsulfate · Handa Oncol · 2026
  • Cabometyx Cabozantinib S-Malate · Exelixis INC · 2016

Drugs in development for kidney cancer (renal cell carcinoma)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CadonilimabAK104Phase 331 trials

    Akeso · Hepatocellular Carcinoma, Gastric / Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

  • ZanzalintinibXL092Phase 311 trials

    Exelixis · Colorectal Cancer, Renal Cell Carcinoma, Head and Neck Squamous Cell Carcinoma

  • Intismeran autogeneV940, mRNA-4157Phase 310 trials

    Merck & Co. · Non-small Cell Lung Cancer, Melanoma, Bladder Cancer

  • AbexinostatPCI-24781Phase 35 trials

    Xynomic Pharmaceuticals, Inc. · Lymphoma, Follicular, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma

  • ONC-392Gotistobart, BNT316Phase 35 trials

    OncoC4, Inc. · Non Small Cell Lung Cancer, Ovarian Cancer, Advanced Solid Tumor

  • rHuPH20Phase 35 trials

    Bristol Myers Squibb · Melanoma, Relapsing-remitting Multiple Sclerosis, Clear Cell Renal Cell Carcinoma

  • AL8326Phase 34 trials

    Advenchen Pharmaceuticals, LLC. · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms

  • GimistotugBGB-A445Phase 34 trials

    BeOne Medicines (BeiGene) · Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma

  • CasdatifanAB521Phase 33 trials

    Arcus Biosciences, Inc. · Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma (RCC)

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • EnvafolimabPhase 24 trials

    3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • REGN5678NezastomigPhase 23 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • ST-1898Phase 23 trials

    Beijing Scitech-Mq Pharmaceuticals Limited · Advanced Renal Cell Carcinoma, Differentiated Thyroid Carcinoma, Unresectable or Metastatic Melanoma

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • GI-102Phase 22 trials

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • AB-2100Integrated Circuit T cellsPhase 21 trial

    Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

More on kidney cancer (renal cell carcinoma): recruiting trials · published research

Related in oncology: Breast cancer · Non-small cell lung cancer · Small cell lung cancer · Prostate cancer · Colorectal cancer · Melanoma · Ovarian cancer · Pancreatic cancer · Bladder and urothelial cancer · Liver cancer (hepatocellular carcinoma)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.